High materiality7/10
Revolution Medicines price target raised to $275 from $240 at Guggenheim
Why it may matterVerify against the original reporting
Target raised; upside potential
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Guggenheim raises RVMD price target to $275; current price $221.15; implied upside; price change since signal: -6.
- Guggenheim raises RVMD PT to $275; price $221.15.
Key facts
- 01
Target: $275
- 02
Posted price: $221.15
- 03
Analyst firm: Guggenheim
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.